Association between EGFR-TKI resistance and efficacy of radiotherapy for brain metastases from EGFR-mutant lung adenocarcinoma

Anticancer Research

Volumn 33, Issue 4, 2013, Pages 1649-1656

  Hirata, Hidenari ^a   Nakamura, Katsumasa ^b   Kunitake, Naonobu ^a   Shioyama, Yoshiyuki ^b   Sasaki, Tomonari ^b   Ohga, Saiji ^b   Nonoshita, Takeshi ^a   Yoshitake, Tadamasa ^b   Asai, Kaori ^b   Inoue, Kouji ^a   Nagashima, Akira ^a   Ono, Minoru ^a   Honda, Hiroshi ^b  

^a KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Brain metastases; EGFR; Lung adenocarcinoma; Radiotherapy; Resistance; TKI

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG ADENOCARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POINT MUTATION; PRIORITY JOURNAL; RADIATION DOSE; STEREOTACTIC RADIOTHERAPY; STEREOTACTIC TREATMENT; WILD TYPE;

ADENOCARCINOMA; ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; PROGNOSIS; PROTEIN KINASE INHIBITORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84876758037     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Porta R, Sanchez-Torres JM, Paz-Ares L, Massuti B, Reguart N, Mayo C, Lianes P, Queralt C, Guillem V, Salinas P, Catot S, Isla D, Pradas A, Gurpide A, de Castro J, Polo E, Puig T, Taron M, Colomer R and Rosell R: Brain metastases from lung cancer responding to erlotinib: The importance of EGFR mutation. Eur Respir J 37: 624-631, 2011.
2. Jackman D, Pao W, Riely GJ, Engelman JA, Kris MG, Janne PA, Lynch T, Johnson BE and Miller VA: Clinical definition of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. J Clin Oncol 28: 357-360, 2010.
3. Omuro AM, Kris MG, Miller VA, Franceschi E, Shah N, Milton DT and Abrey LE: High incidence of disease recurrence in the brain and leptomeninges in patients with non-small cell lung carcinoma after response to gefitinib. Cancer 103: 2344-2348, 2005. (Pubitemid 40686581)
4. Lee YJ, Choi HJ, Kim SK, Chang J, Moon JW, Park IK, Kim JH and Cho BC: Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with non-small cell lung cancer. Cancer 116: 1336-1343, 2010.
5. Gow CH, Chien CR, Chang YL, Chiu YH, Kuo SH, Shih JY, Chang YC, Yu CJ, Yang CH and Yang PC: Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response. Clin Cancer Res 14: 162-168, 2008.
6. Eichler AF, Kahle KT, Wang DL, Joshi VA, Willers H, Engelman JA, Lynch TJ and Sequist LV: EGFR mutation status and survival after diagnosis of brain metastasis in non-small cell lung cancer. Neuro Oncol 12: 1193-1199, 2010.
7. Lee HL, Chung TS, Ting LL, Tsai JT, Chen SW, Chiou JF, Leung HW and Liu HE: EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases. Radiat Oncol 7: 181, 2012.
8. Das AK, Sato M, Story MD, Peyton M, Graves R, Redpath S, Girard L, Gazdar AF, Shay JW, Minna JD and Nirodi CS: Non-small cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation. Cancer Res 66: 9601-9608, 2006. (Pubitemid 44623659)
9. Benavente S, Huang S, Armstrong EA, Chi A, Hsu KT, Wheeler DL and Harari PM: Establishment and characterization of a model of acquired resistance to epidermal growth factor receptor targeting agents in human cancer cells. Clin Cancer Res 15: 1585-1592, 2009.
10. Huang S, Benavente S, Armstrong EA, Li C, Wheeler DL and Harari PM: p53 Modulates acquired resistance to EGFR inhibitors and radiation. Cancer Res 71: 7071-7079, 2011.
11. Yatabe Y, Hida T, Horio Y, Kosaka T, Takahashi T and Mitsudomi T: A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer. J Mol Diagn 8: 335-341, 2006. (Pubitemid 44063810)
12. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D and Verweij J: New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45: 228-247, 2009.
13. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG and Byhardt R: Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37: 745-751, 1997. (Pubitemid 27181303)
14. Huang SM, Li J, Armstrong EA and Harari PM: Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Res 62: 4300-4306, 2002. (Pubitemid 34827286)
15. Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins SA, Chinnaiyan AM and Harari PM: Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva). Cancer Res 65: 3328-3335, 2005. (Pubitemid 40524617)
16. Milas L, Mason K, Hunter N, Petersen S, Yamakawa M, Ang K, Mendelsohn J and Fan Z: In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res 6: 701-708, 2000. (Pubitemid 30111496)
17. Kosaka T, Yamaki E, Mogi A and Kuwano H: Mechanisms of resistance to EGFR TKIs and development of a new generation of drugs in non-small cell lung cancer. J Biomed Biotechn 2011: 165214, 2011.
18. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE and Schmitz PI: Identification of prognostic factors in patients with brain metastases: A review of 1292 patients. Int J Radiat Oncol Biol Phys 43: 795-803, 1999. (Pubitemid 29152652)
19. Gow CH, Chang YL, Hsu YC, Tsai MF, Wu CT, Yu CJ, Yang CH, Lee YC, Yang PC and Shih JY: Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitornaive non-small cell lung cancer. Ann Oncol 20: 696-702, 2009.